MedTrace Logo

Zenith® TXD Post-market Surveillance in Japan

NCT02663739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2023-06-07

No results posted yet for this study

Summary

The study is a post-market surveillance study required by Japanese Regulatory Authorities as a condition of approval

Conditions

  • Aortic Dissection

Interventions

DEVICE

Zenith® TXD

Zenith® TXD Dissection Stent Graft System for treatment of patients with aortic dissection of the descending thoracic aorta

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • Masaaki Kato, MD · Morinomiya Hospital

  • Kimihiko Kichikawa, MD · Nara Medical University Hospital

  • Hideyuki Shimizu, MD · Keio University Hospital

  • Joseph Lombardi, MD · The Cooper Health System

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2023-03-28
Completion
2023-03-28

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02663739 on ClinicalTrials.gov